Observational Study in COVID-19 Patients Treated With Remdesivir
NCT ID: NCT05239988
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1004 participants
OBSERVATIONAL
2021-11-24
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159
International SARS-CoV-2 (COVID-19) Infection Observational Study
NCT04385251
The Natural History of Hospitalized COVID-19 Patients
NCT04424992
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373
The Corona Study of Middle Norway
NCT05638178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is a no-profit scientific project, promoted by The FADOI Foundation, the Scientific Society of Internal Medicine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 patients treated with Remdesivir
Patients suffering from SARS-CoV-2 and treated with Remdesivir admitted to Internal Medicine Unit
no experimental intervention
There will not be any experimental intervention. The study will be conducted according with normal clinical practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no experimental intervention
There will not be any experimental intervention. The study will be conducted according with normal clinical practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosed with radiologically documented SARS-CoV-2 pneumonia
* treated with Remdesivir (according to the criteria defined by AIFA\*)
* admitted to Internal Medicine from March 2020 to August 2021.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fadoi Foundation, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Fontanella, MD
Role: STUDY_DIRECTOR
FADOI FOUNDATION
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale "Mons. Giovanni Galliano"
Acqui Terme, (AL), Italy
Ente Ecclesiastico "F. Miulli"
Acquaviva delle Fonti, (BA), Italy
Ospedale di Andria
Andria, (BT), Italy
P.O. di Garbagnate
Garbagnate Milanese, (MI), Italy
Ospedale di Melegnano
Melegnano, (MI), Italy
Ospedale Broni-Stradella
Stradella, (PV), Italy
P.O. di Polistena
Polistena, (RC), Italy
AO "Giuseppe Foscati"
Avellino, , Italy
Ospedale "S. Paolo"
Bari, , Italy
Ospedale di Bentivoglio
Bologna, , Italy
Ospedale Maggiore di Bologna Medicina D
Bologna, , Italy
P.O. "SS. Trinità "
Cagliari, , Italy
Ospedale M. Bufalini di Cesena
Cesena, , Italy
Ospedale di Alba e Bra
Cuneo, , Italy
Ospedale di Faenza
Faenza, , Italy
AOU Careggi
Florence, , Italy
Ospedale "Careggi"
Florence, , Italy
P.O di Frattamaggiore
Frattamaggiore, , Italy
Ospedale Galliera
Genova, , Italy
Ospedale del Mare
Napoli, , Italy
Azienda Ospedaliero Universitaria di Novara
Novara, , Italy
A.O.U. di Perugia
Perugia, , Italy
Ospedale di Rimini - Medicina 1 COVID
Rimini, , Italy
Ospedale di Rimini -Sub intensiva COVID
Rimini, , Italy
Ospedale "Vannini"
Roma, , Italy
Ospedale Fatebenefratelli Isola Tiberina
Roma, , Italy
PO SS Annunziata AOU Sassari
Sassari, , Italy
Ospedale "San Paolo" di Savona
Savona, , Italy
Ospedale "Mauriziano"
Torino, , Italy
Ospedale "Circolo-Macchi"
Varese, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FADOI.02.2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.